Stockreport

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF KELOWNA, BC / ACCESSWIRE / October 9, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery plat [Read more]